Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma

Clinical Laboratory

Volumn 59, Issue 5-6, 2013, Pages 647-653

  Dong, Shang Wen ^a   Zhang, Peng ^a   Zhong, Rong Rong ^a   Liu, Qi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

ESCC; Syk; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; PROTEIN KINASE SYK;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-TYROSINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84879328539     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120414     Document Type: Article

References (26)

1. Amin HM, Hoshino K, Yang H, et al. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia. J Path 2007,212:402-10. (Pubitemid 47099017)
2. Coopman PJ, Do MTH, Barth M, et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000; 406: 742-7.
3. Wang L, Duke L, Zhang PS, et al. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 2003;63:4724-30. (Pubitemid 36951053)
4. Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997;13:444-9. (Pubitemid 27479903)
5. Razin A, Ceder H. DNA methylation and gene expression. Microbiol Rev 1991;55:451-8. (Pubitemid 21895162)
6. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7. (Pubitemid 29070360)
7. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9. (Pubitemid 32695003)
8. Tohyama Y, Yamamura H. Protein tyrosine kinase, syk: a key player in phagocytic cells. J Biochem 2009;145(3):267-73.
9. Mortarino M, Gelain ME, Gioia G, et al. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases. Vet Immunol Immunopathol 2009;128(4):395-401.
10. Boelens J, Lust S, Van Bockstaele F, et al. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia. Leuk Res 2009;33(10):1335-43.
11. Geahlen RL, Syk and pTyr'd: Signaling through the B cell antigen receptor. Biochim Biophys Acta 2009;1793(7):1115-27.
12. Coopman PJ, Mueller SC. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 2006;Sep 28,241(2):159-73.
13. Ulanova M, Puttagunta L, Marcet-Palacios M, et al. Syk tyrosine kinase participates in beta-1-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005;288:L497-L507. (Pubitemid 40229515)
14. Yamada T, Fujieda S, Yanagi S, et al. Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 2001;166:538-43. (Pubitemid 32038474)
15. Inatome R, Yanagi S, Takano T, Yamamura H. A critical role for Syk in endothelial cell proliferation and migration. Biochem Biophys Res Commun 2001;286:195-9. (Pubitemid 32917669)
16. Tsujimura T, Yanagi S, Inatome R, et al. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells. FEBS Lett 2001;Feb2;489(2-3):129-33.
17. Tsuchida S, Yanagi S, Inatome R, et al. Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem 2000;127:321-7. (Pubitemid 30136916)
18. Hoeller C, Thallinger C, Pratscher B, et al. The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells. J Invest Dermatol 2005;124:1293-9. (Pubitemid 40847418)
19. DONG SW, MA L, XU N, et al. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer. Neoplasma 58,1,2011,89-95.
20. Ma L, Dong S, Zhang P, et al. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Clin Lab 2010;56(9-10):407-16.
21. Toyama T, Iwase H, Yamashita H, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2003;189:97-102. (Pubitemid 35351524)
22. Yuan Y, Mendez R, Sahin A, et al. Hypermet hylation leads to silencing of the Syk gene in human breast cancer. J Cancer Res 2001;61(14):5558-61. (Pubitemid 32694942)
23. Yuan Y, Wang J, Li J, et al. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 2006;Nov 15;12(22):6687-95.
24. Wang S, Ding YB, Chen GY, et al. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. J World J Gastroenterol 2004;10(12):1815-8. (Pubitemid 38931212)
25. Liu YX, Ding YB, Yang Li, et al. Relationship between hypermethylation of Syk gene in promoter and oncogenesis, metastasis of gastric carcinoma. ACTA Universitatis Medicinalis Nan Jing (Natural Science) 2006;26(3):169-94.
26. Goodman PA, Burkhardt N, Juran B, et al. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia. J Oncogene 2003,22(16):2504-14. (Pubitemid 36560733)